Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone

Blood Cancer Journal, Published online: 25 November 2019; doi:10.1038/s41408-019-0254-0Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone

Source: Blood Cancer Journal - November 24, 2019 Category: Hematology Authors: Timothy M. Schmidt Benjamin G. Barwick Nisha Joseph Leonard T. Heffner Craig C. Hofmeister Leon Bernal Madhav V. Dhodapkar Vikas A. Gupta David L. Jaye Jiayi Wu Subir Goyal Zhengjia Chen Lawrence H. Boise Sagar Lonial Ajay K. Nooka Jonathan L. Kaufman Source Type: research